Activated T cells - Cyclacel Pharmaceuticals
Alternative Names: Xcellerated T Cells; XcyteDynabeadsLatest Information Update: 24 Oct 2021
At a glance
- Originator Xcyte Therapies
- Class Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autoimmune disorders; Chronic lymphocytic leukaemia; Multiple myeloma; Non-Hodgkin's lymphoma; Prostate cancer; Renal cancer
Most Recent Events
- 13 Oct 2005 Discontinued - Phase-I/II for Prostate cancer in USA (IV-infusion)
- 13 Oct 2005 Discontinued - Phase-I/II for Renal cancer in USA (IV-infusion)
- 13 Oct 2005 Discontinued - Preclinical for Autoimmune disorders in USA (unspecified route)